You Searched For "adar poonawalla vaccine" and got 20 results
Sort By:
2 mins read
The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla
The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…
2 mins read
Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market
SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…
4 mins read
COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla
"It will probably take two or three years for every Indian to get inoculated, not just because o…
PTI
1 min read
Serum Institute CEO says vaccine development is like rollercoaster
"Developing a vaccine is like riding a rollercoaster; there are plenty of ups and downs. Sometim…
3 mins read
Adar Poonawalla says SII will seek emergency use authorisation for AstraZeneca COVID-19 vaccine in two weeks
Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting …
1 min read
Cyrus Poonawalla, India’s vaccine king, multiplied his wealth nearly 5 times in a decade
He founded the Serum Institute of India in 1966, with a capital of $12,000. His idea was to de…
3 mins read
If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?
Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…
2 mins read
Serum Institute of India buys into IPO-bound insurance unicorn PolicyBazaar, as True North sells part stake in secondary sale
The investment firm True North (formerly India Value Fund) has sold a part of its stake in Polic…
3 mins read
Should have a vaccine for COVID-19 by 2021, will not patent it: Serum Institute's Adar Poonawalla
"I urge everybody to understand that a lockdown is not going to get rid of all the cases. I would …
PTI
3 mins read
SII's Oxford-Astra Zeneca COVID-19 vaccine to cost $3-4 to Indian government, price likely to be double in private markets
Only after meeting their requirements, "the private market will open up where the pricin…
PTI
1 min read
It's your money. If you want to blow it up, fine: Adar's father on vaccine bet
New Delhi, Nov 13 (IANS) Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is puttin…
2 mins read
Centre seeks 300-400 mn vaccine doses, says SII's Poonawalla
Pune, Nov 28 (IANS) The Government of India is looking at getting 300-400 million doses of coronavi…
1 min read
DGCI allows Serum Institute to export malaria vaccine to UK
The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of th…
PTI
2 mins read
India to launch its first indigenously developed cervical cancer vaccine in the next few months
Cervical cancer ranks as the 2nd most prevalent cancers in India and accounts for nearly one-fou…
2 mins read
COVID-19 vaccination for senior citizens to start from March 1 in India — will be free at government hospitals
The Indian government announced today that COVID-19 vaccine doses for senior citizens will be avail…
2 mins read
If you have just recovered from COVID-19, experts say you don't need to join in on the rush for vaccination immediately
Disclaimer: This should not be considered medical advice. Please check with your doctor on medical …
2 mins read
Covishield vaccine priced at ₹400 and ₹600 for state hospitals and private hospitals respectively, to be available in medical stores after 4-5 months
Vaccine leader Serum Institute of India (SII), which produces the Astrazeneca and Oxford vaccine…
2 mins read
Oxford-AstraZeneca COVID-19 vaccine approval is 'unthinkable', claims European watchdog
As the country awaits the UK's approval to the AstraZeneca-Oxford vaccine before giving nod for Eme…
2 mins read
India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates
The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …
3 mins read
UK approves Oxford-AstraZeneca COVID-19 vaccine
The Oxford-AstraZeneca COVID-19 vaccine — also called the ‘jab’ — has been approved for mass vaccin…